CLINICAL_TRIALS trial_result · 2009-07-09

Clinical Trial Update: CUTE (Chronic Urticaria Treatment Evaluation) [Phase 4]

Phase 4 trial update from UCB Pharma evaluating treatment for chronic idiopathic urticaria, with the study completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: UCB Pharma | Conditions: Chronic Idiopathic Urticaria | Phase 4 | Status: COMPLETED | Results posted: 2009-07-09